{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:05:43Z","timestamp":1785283543136,"version":"3.55.0"},"reference-count":46,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"UCB Pharma S.A"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"published-print":{"date-parts":[[2022,8,18]]},"DOI":"10.1080\/14737167.2022.2063842","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T18:55:00Z","timestamp":1649703300000},"page":"941-953","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4618-6894","authenticated-orcid":false,"given":"N\u00e9boa","family":"Zozaya","sequence":"first","affiliation":[{"name":"Department of Health Economics, Weber, Madrid, Spain"},{"name":"Department of Quantitative Methods in Economics and Management, University Las Palmas de Gran Canaria, Las Palmas, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Abdalla","sequence":"additional","affiliation":[{"name":"Department of Health Economics, Weber, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Alfonso Zamora","sequence":"additional","affiliation":[{"name":"Department of Management, Psoriasis and Psoriatic Arthritis Patient and Family Association (Acci\u00f3n Psoriasis), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Balea Filgueiras","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ferrol University Hospital Complex, La Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-0771","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Carrascosa Carrillo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Germans Trias I Pujol University Hospital, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Delgado S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Management, Spanish Society of Hospital Pharmacy (SEFH). Department of Pharmacy, Son Espases University Hospital, Illes Balears, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Dolz Sinisterra","sequence":"additional","affiliation":[{"name":"Department of Management, Doctor Peset University Hospital, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-6993","authenticated-orcid":false,"given":"Antonio","family":"Garc\u00eda-Ruiz","sequence":"additional","affiliation":[{"name":"Health Economics and Rational Use of Medicines. Department of Pharmacology and Clinical Therapeutics, Biomedical Research Institute of M\u00e1laga (IBIMA), University of M\u00e1laga, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Herranz Pinto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, La Paz University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Manfredi","sequence":"additional","affiliation":[{"name":"Department of Management, Psoriasis and Psoriatic Arthritis Patient and Family Association (Acci\u00f3n Psoriasis), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez Olmos","sequence":"additional","affiliation":[{"name":"Andalusian Public Health School (EASP), Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Morales de Los R\u00edos Luna","sequence":"additional","affiliation":[{"name":"Department of Nursing, Gregorio Mara\u00f1\u00f3n University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-0952","authenticated-orcid":false,"given":"Lluis","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ros","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rheumatology and Cardiac Transplantation, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-8027","authenticated-orcid":false,"given":"\u00c1lvaro","family":"HIdalgo-Vega","sequence":"additional","affiliation":[{"name":"Weber Foundation, Madrid, Spain"},{"name":"Department of Economic Analysis and Finances, University of Castilla-La Mancha, Toledo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16504"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-017-0871-0"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2017.1360545"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.743180"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7"},{"issue":"7","key":"cit0007","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1468-3083.2006.01659.x","volume":"20","author":"Carrascosa J","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"cit0008","unstructured":"Acci\u00f3n Psoriasis. Encuesta NEXT sobre necesidades actuales y expectativas de futuro en psoriasis en Espa\u00f1a. Informe de resultados 2019 [Internet]. 2020 [cited 2021 Apr 29]. Available from: https:\/\/www.accionpsoriasis.org\/recursos\/publicaciones\/otras-publicaciones.html"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3386"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13150"},{"key":"cit0011","volume":"4","author":"Sbidian E","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00511-1"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15920"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34293-y"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1767590"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.791"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15088"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.3390\/ph15010095"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.2020.5006"},{"key":"cit0020","first-page":"14","volume":"14","author":"Monks G","year":"2021","journal-title":"J Clin Aesthetic Dermatol"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.018"},{"key":"cit0022","unstructured":"European Medicines Agency (EMA). Bimzelx. summary of product characteristics. 2021. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bimzelx-epar-product-information_en.pdf [cited 2021 Jun 23]"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.937"},{"key":"cit0024","first-page":"281","volume":"32","author":"Zozaya N","year":"2018","journal-title":"BioDrugs Clin Immunother Biopharm Gene Ther"},{"key":"cit0025","volume":"16","author":"Goetghebeur MM","year":"2018","journal-title":"Cost Eff Resour Alloc CE"},{"key":"cit0026","unstructured":"Zozaya N, Oliva Moreno J, HIdalgo-Vega A. Multi-criteria decision analysis in healthcare. Its isefulness and limitations for decision making . [Internet]. Weber Foundation; 2018. Available from: https:\/\/weber.org.es\/wp-content\/uploads\/2021\/03\/libro_admc_17_x_24_ingles_digital.pdf [cited 2020 Sep 24]"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00126-4"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102388"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00125-2"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102383"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60125-8"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31713-6"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33161-7"},{"key":"cit0034","unstructured":"ClinicalTrials.gov (NIH U.S. National Library of Medicine). A phase 3, multicenter, randomized, double-blind, placebo-controlled, active reference (Adalimumab) study evaluating the efficacy and safety of bimekizumab in the treatment of subjects with active psoriatic arthritis (BE OPTIMAL) [internet]. clinicaltrials.gov; 2021 [cited 2021 Dec 13]. Report No.: NCT03895203. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03895203"},{"key":"cit0035","unstructured":"Bay\u00f3n Yusta J, Guti\u00e9rrez Iglesias A, Galnares-Cordero L, et al. Proyecto metodol\u00f3gico. S\u00edntesis de informaci\u00f3n relevante de apoyo a los MCDA (an\u00e1lisis de decisi\u00f3n multicriterio) para la toma de decisiones [Internet]. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Tecnolog\u00edas Sanitarias del Pa\u00eds Vasco; 2019 [cited 2019 Apr 26]. Available from 2019 Apr 26: http:\/\/www.ogasun.ejgv.euskadi.eus\/r51-catpub\/es\/k75aWebPublicacionesWar\/k75aObtenerPublicacionDigitalServlet?R01HNoPortal=true&N_LIBR=052312&N_EDIC=0001&C_IDIOM=es&FORMATO=.pdf"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0135-0"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.827"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1121-6"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225938"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0653-1"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00487"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-017-0048-x"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0803-9"},{"key":"cit0044","unstructured":"Zozaya N, Galindo J, Alcal\u00e1 B, et al. El an\u00e1lisis de decisi\u00f3n multi-criterio como herramienta para la toma de decisiones en medicamentos hu\u00e9rfanos: una revisi\u00f3n de la literatura. IX Congreso Internacional de Medicamentos Hu\u00e9rfanos y Enfermedades Raras, Sevilla; 2019. [cited 2021 Oct 21]. Available from: www.farmaceuticosdesevilla.es"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0555-3"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3258-9"}],"container-title":["Expert Review of Pharmacoeconomics &amp; Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2022.2063842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T21:56:04Z","timestamp":1700430964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2022.2063842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8,18]]}},"alternative-id":["10.1080\/14737167.2022.2063842"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2022.2063842","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}